Search for: "REDDY PHARMACEUTICALS, INC." Results 61 - 80 of 96
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2010, 10:58 pm
(Patent Docs) Prilosec (Omeprazole) – US: Dr Reddy’s wins attorney’s fees from AstraZeneca in Prilosec OTC case (Orange Book Blog) Protonix (Pantoprazole) – US: Jury finds Protonix patent infringed by Teva (The IP Factor) Restasis (Ciclosporin) – Restasis royalty dispute finally settles (IP finance) Tarceva (Erlotinib) – India: Roche and Tarceva in Delhi HC again, this time vs Natco (Spicy IP) (Generic Pharmaceuticals and IP) Viagra (Sildenafil)… [read post]
8 Oct 2009, 6:05 am
Reddy’s, Barr and Purepac (Patent Baristas) Renagel (Sevelamer) – US: Genzyme files patent infringement suit against Endo Pharmaceuticals following Para IV challenge (Patent Docs) Roundup Ready cotton seed – US: Monsanto files patent infringement suits against Brent M Hargrove and Larry H Lytle based on defendants’ use of cotton seed produced from earlier planted Roundup Ready cotton seed (Patent Docs) Seroquel (Quetiapine) – US:… [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
7 Mar 2016, 1:55 am
.* A Monsanto case that could alter the dynamics of technology transfer to IndiaKatfriend Prashant Reddy pens about a wide legal dispute between Monsanto and some Indian seed companies, backed by the Indian government (& state governments). [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs)   General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction… [read post]
24 Aug 2011, 12:33 am by Marie Louise
(BIOtechNOW) Matrix tablets and scope of protection: a reader asks (The SPC Blog) UK: Manual of Patent Practice revised to include guidelines for assessing obviousness of ‘selection inventions’ in light of Dr Reddy (IPKat) US: Strength in numbers? [read post]
23 May 2019, 10:47 am by Audrey A Millemann
In Nuvo Pharmaceuticals Designated Activity Co. v Reddy’s Laboratories Inc., 2019 U.S. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
8 Dec 2020, 1:00 pm by Olivia Cross
Instead, the ANDA applicants must simply prove that their proposed generic product is bioequivalent of an existing pharmaceutical, often called the innovator drug. [read post]
27 Aug 2011, 7:55 pm
Reddy's Labs., 533 F.3d 1353, 1356 (Fed. [read post]
2 Feb 2018, 1:31 pm by Gregory Sephton
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
2 Apr 2013, 10:33 am by Anubha Sinha
George Yu, an experienced patent litigation lawyer at Schiff Hardin LLP on the legality of reverse payment settlements in the pharmaceutical sector- a strategy wherein a patent holder pays a generic pharmaceutical manufacturer to delay or withdraw any challenges to patent validity. [read post]
30 Dec 2016, 2:58 pm
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off cup case |… [read post]